Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.02.022Source: DataRank Database

Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy is a research paper published in Transplantation and Cellular Therapy (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.18)OA: greenTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Michael D. Keller ORCID,Jennifer Michlitsch ORCID,Paibel Aguayo‐Hiraldo ORCID,Karin Chen ORCID,Mohammad Zahid Hossain ORCID

Live enrichment

PubMed:38447751 PMC:PMC11182654 OpenAlex:https://openalex.org/W4392362162

National Center for Advancing Translational Sciences

Grant: U01TR002487

National Center for Advancing Translational Sciences

FWCI

0.18

Citation Percentile

0.5%

Citation Trend

2025

greenLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11182654/pdf/nihms-1972181.pdf

GREENhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11182654/pdf/nihms-1972181.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11182654/pdf/nihms-1972181.pdf

publisherhttps://api.elsevier.com/content/article/PII:S2666636724002471?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666636724002471?httpAccept=text/plain

Fields of Study

CAR-T cell therapy researchBiomedical Ethics and RegulationBiomedical and Engineering EducationMedicineHumansCell- and Tissue-Based TherapyImmunotherapyClinical Trials as TopicPharmacovigilanceProduct Surveillance, Postmarketing

MeSH Terms

Clinical Trials as TopicHumansImmunotherapyProduct Surveillance, PostmarketingPharmacovigilanceCell- and Tissue-Based Therapy

Keywords

Clinical trialMedicinePharmacovigilancePatient safetyDrug developmentAdverse effectPharmacologyDrugHealth carePathologyPolitical scienceDrug safetySafety SurveillanceCell And Gene TherapiesAcademic Institutions

Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy

FAIR Checklist

Authors (10)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)